Peer-reviewedCC BYBiomedicines
Transcriptomic Assessment of PD-L1 (CD274) in NSCLC: Biological Significance, Clinical Relevance, and Methodological Challenges
- 1Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, in Katowice, 40-055 Katowice, Poland;
- 2IIIrd Radiotherapy and Chemotherapy Department, Maria Skłodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland;
- 3Department of Histology and Cell Pathology, Faculty of Medical Sciences in Zabrze, in Katowice, 40-055 Katowice, Poland; (P.L.); (M.W.); (E.T.); (A.S.)
Related
- Profiling Amino Acid Substitutions in Proteomic Datasets of Alzheimer’s Disease Reveals Biological Significance
- Recurrent anaphylaxis highlighting methodological variability and diagnostic challenges in the basophil activation test: a case report.
- Understanding rhythmic behavior in infancy: Perspectives for addressing developmental, methodological, and analytical challenges
- Recognizing senescent vascular smooth muscle cells in diabetic atherosclerosis: biomarkers, transcriptomic signatures, and methodological validity
- Integrated Transcriptomic and Regulatory Network Analysis Reveals Distinct Molecular Subtypes with Prognostic Significance in Clear Cell Renal Cell Carcinoma
BibTeX
@article{baron2026transcriptomic,
title = {{Transcriptomic Assessment of PD-L1 (CD274) in NSCLC: Biological Significance, Clinical Relevance, and Methodological Challenges}},
author = {Maciej Baron and Iwona Jabłońska and Piotr Lewandowski and Małgorzata Wachowicz and Eliza Tomkiewicz and Adam Skrzypiec and Bogna Drozdzowska},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701400},
note = {CC BY},
}
RIS
TY - JOUR
TI - Transcriptomic Assessment of PD-L1 (CD274) in NSCLC: Biological Significance, Clinical Relevance, and Methodological Challenges
AU - Maciej Baron
AU - Iwona Jabłońska
AU - Piotr Lewandowski
AU - Małgorzata Wachowicz
AU - Eliza Tomkiewicz
AU - Adam Skrzypiec
AU - Bogna Drozdzowska
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701400
SN - 2227-9059
ER -